CD4 and infection: A recent in vivo study using retroviral vector delivery of NullBasic to primary human CD4+ T cells and engraftment in a NSG mouse model demonstrated undetectable viral RNA in plasma samples up to day 14 post-infection and significantly reduced viral RNA levels in tissue-derived CD4+ T cells (Jin et al., 2019).